William Blair analysts Raju Prasad, Myles Minter, and Matt Larew describe in Client Focus the technology advancements and medical breakthroughs in genomic medicines like the mRNA vaccines that are ushering in a new era of healthcare.

Those discoveries have caught the eyes of investors as well. John Sonnier, with the firm’s investment banking biopharma team, discusses the latest trends. This edition also includes an informative Q&A on inflation with Olga Bitel, a global strategist with William Blair Investment Management.

Read Client Focus